Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients

Haemophilia

Volumn 13, Issue 6, 2007, Pages 734-739

  Ghosh, Kanjaksha ^a   Shetty, S ^a   Kulkarni, B ^a  

^a KEM HOSPITAL   (India)

Author keywords

Severe haemophilia; Thromboelastography

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR CONCENTRATE;

ARTHROPATHY; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EX VIVO STUDY; FIBRINOLYSIS; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION FACTORS; CHRONIC DISEASE; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MALE; RECOMBINANT PROTEINS; THROMBELASTOGRAPHY;

EID: 35548943953     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01544.x     Document Type: Article

References (15)

1. Butenas S, Van't Veer C, Mann KG. Normal thrombin generation. Blood 1999; 94: 2169-78.
2. Hemker HC, Giesen PL, Ramjee M, Wagenwood R, Beguin S. The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb Haemost 2000; 83: 589-91.
3. Kjalke M, Ezban M, Monroe DM, Hoffman M, Roberts HR, Hedner U. High dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in trombocytopenia - like conditions in a cell based model system. Br J Haematol 2001; 114: 114-20.
4. Butenas S, Branda RF, Van't Veer C, Cowthern K, Mann KG. Platelets and phospholipids in tissue factor initiated thrombin generation. Thromb Haemost 2001; 86: 660-7.
5. Dacie JV, Lewis SM. Practical Haematology, 8th edn. UK: Churchill Livingstone, 1999.
6. Brummel KE, Paradis SG, Butenas S, Mann KG. Thrombin functions during tissue factor induced blood coagulation. Blood 2002; 100: 148-52.
7. Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem 1999; 274: 22862-70.
8. Cowthern KM, van't Veer C, Lock JB, D'Lorenzo ME, Branda RF, Mann KG. Blood coagulation in haemophilia A and haemophilia C. Blood 1998; 91: 4581-92.
9. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
10. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in haemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2003; 2: 102-10.
11. Sorensen B, Johansen P, Christiansen P, Woelke P, Ingerslev J. Whole blood coagulation thromboelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-8.
12. Ghosh K, Shetty S, Pathare A, Mohanty D. Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one stage assay. Haemophilia 2001; 7: 9-12.
13. Ghosh K, Shetty S, Pathare A, Mohanty D. Epsilon aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro. Acta Haematol 2000; 103: 67-72.
14. Grunewald M, Siegemund A, Grunewald A, Konegan A, Kokscch M, Griesshammer M. Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia. Haemophilia 2002; 8: 768-75.
15. Rognoni F, Garzia A, Ariano M. Action of 3,4,5-trimethoxybenzoyl epsilon amino caproic acid on platelet aggregation and on the activation of plasminogen by streptokinase. Atherosclerosis 1971; 14: 375-8.